Several studies implicate a pathogenic role of NLRP3 in PD via IL-1β and IL-18-dependent pyroptosis. α-Synuclein activates TLR2 and TLR4-mediated NLRP3 inflammasome assembly and caspase-1 maturation both (149). Here, NLRP3 is linked to Parkinson disease.